These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. Finazzi G, Barbui T. Leukemia; 2008 Aug; 22(8):1494-502. PubMed ID: 18596737 [Abstract] [Full Text] [Related]
23. [Diagnosis and therapy of polycythemia vera in the era of JAK2]. Lengfelder E. Dtsch Med Wochenschr; 2013 Feb; 138(7):331-6. PubMed ID: 23393003 [Abstract] [Full Text] [Related]
24. A contemporary approach to the diagnosis and management of polycythemia vera. Tefferi A. Curr Hematol Rep; 2003 May; 2(3):237-41. PubMed ID: 12901345 [Abstract] [Full Text] [Related]
30. Polycythemia vera. Landolfi R, Nicolazzi MA, Porfidia A, Di Gennaro L. Intern Emerg Med; 2010 Oct 01; 5(5):375-84. PubMed ID: 20237866 [Abstract] [Full Text] [Related]
31. Polycythemia vera: a review. Golden C. Clin J Oncol Nurs; 2003 Oct 01; 7(5):553-6. PubMed ID: 14603552 [Abstract] [Full Text] [Related]
32. The haematocrit and platelet target in polycythemia vera. Di Nisio M, Barbui T, Di Gennaro L, Borrelli G, Finazzi G, Landolfi R, Leone G, Marfisi R, Porreca E, Ruggeri M, Rutjes AW, Tognoni G, Vannucchi AM, Marchioli R, European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP) Investigators. Br J Haematol; 2007 Jan 01; 136(2):249-59. PubMed ID: 17156406 [Abstract] [Full Text] [Related]
33. No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials. Barbui T, Carobbio A, Ghirardi A, Masciulli A, Rambaldi A, Vannucchi AM. Haematologica; 2017 Jun 01; 102(6):e219-e221. PubMed ID: 28255021 [No Abstract] [Full Text] [Related]
34. [Polycythaemia vera--diagnosis and therapy]. Lechner K, Geissler K, Gisslinger H. Wien Klin Wochenschr; 1999 Aug 20; 111(15):582-9. PubMed ID: 10483672 [Abstract] [Full Text] [Related]
36. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies. Landolfi R, Di Gennaro L, Novarese L, Patrono C. Semin Thromb Hemost; 2006 Apr 20; 32(3):251-9. PubMed ID: 16673279 [Abstract] [Full Text] [Related]
37. New Therapeutic Approaches in Polycythemia Vera. Falchi L, Newberry KJ, Verstovsek S. Clin Lymphoma Myeloma Leuk; 2015 Jun 20; 15 Suppl(0):S27-33. PubMed ID: 26297275 [Abstract] [Full Text] [Related]
38. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients. Bachleitner-Hofmann T, Grumbeck E, Gisslinger H. Thromb Res; 2003 Jun 20; 112(4):229-32. PubMed ID: 14987916 [Abstract] [Full Text] [Related]
39. Treatment options for essential thrombocythemia and polycythemia vera. Vannucchi AM, Guglielmelli P, Pieri L, Antonioli E, Bosi A. Expert Rev Hematol; 2009 Feb 20; 2(1):41-55. PubMed ID: 21082994 [Abstract] [Full Text] [Related]
40. Current and future treatment options for polycythemia vera. Griesshammer M, Gisslinger H, Mesa R. Ann Hematol; 2015 Jun 20; 94(6):901-10. PubMed ID: 25832853 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]